Andrew Hotchkiss is President of Lilly’s pharmaceutical operations across Europe and Canada. He is Chair of the European Markets Committee of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and sits in the EFPIA’s Patient Access Committee. Andrew joined Lilly in 1985 as a Sales Representative in the UK. Over a career spanning 29 years, Mr Hotchkiss has held many senior leadership positions within sales and marketing operations and strategic planning, including General Manager positions in Italy and the UK. Prior to his current role, Andrew was Lilly Vice President, International, Oncology.